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Summary
Introduction—The cleavage stage mouse embryo is composed of superficially equivalent
blastomeres that will generate both the embryonic inner cell mass (ICM) and the supportive
trophectoderm (TE). However, it remains unsettled whether the contribution of each blastomere to
these two lineages can be accounted for by chance. Addressing the question of blastomere cell fate
may be of practical importance, as preimplantation genetic diagnosis (PGD) requires removal of
blastomeres from the early human embryo. To determine if blastomere allocation to the two
earliest lineages is random, we developed and utilized a recombination-mediated, non-invasive
combinatorial fluorescent labeling method for embryonic lineage tracing.
Results—When we induced recombination at cleavage stages, we observed a statistically
significant bias in the contribution of the resulting labeled clones to the trophectoderm or the inner
cell mass in a subset of embryos. Surprisingly, we did not find a correlation between localization
of clones in the embryonic and abembryonic hemispheres of the late blastocyst and their allocation
to the TE and ICM, suggesting that TE-ICM bias arises separately from embryonic-abembryonic
bias. Rainbow lineage tracing also allowed us to demonstrate that the bias observed in the
blastocyst persists into post-implantation stages, and therefore has relevance for subsequent
development.
Discussion—The Rainbow transgenic mice that we describe here have allowed us to detect
lineage-dependent bias in early development. They should also enable assessment of the
developmental equivalence of mammalian progenitor cells in a variety of tissues.
© 2012 Elsevier Inc. All rights reserved.
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Introduction
During the cleavage stages of preimplantation development, the embryo undergoes serial
cell divisions to produce 2, 4, and 8 seemingly identical cells dubbed blastomeres. After
three additional cell divisions, the embryo will have formed a structure known as the
blastocyst. The blastocyst consists of two distinct cell populations: the trophectoderm (TE),
and the inner cell mass (ICM). The TE comprises the majority of the blastocyst and will
become the placenta, while the ICM will give rise to the embryo proper and supportive
tissues of the primitive endoderm. Although the embryonic blastomeres appear similar, it is
a question of considerable interest whether each has an equal probability of giving rise to
either the TE or ICM, or instead possesses an intrinsic lineage bias (reviewed in [1-2]).
Groundbreaking early studies using radioactive tracers and dyes showed that individual
blastomeres have the potential to contribute to both the TE and ICM [3-4]. More recently,
microinjection of a plasmid encoding Cre recombinase into single blastomeres of embryos
containing a Cre-dependent lacZ reporter gene, found no apparent bias in contribution to
different regions of the blastocyst [5]. However, distinct patterns of clone contribution to
different tissues were observed in postimplantation embryos [5]. The methods employed in
these early experiments could only be used to label one blastomere per embryo, and
therefore, the interactions between multiple blastomere daughters could not be examined
[3-4]. It has also been suggested that perturbations resulting from invasive labeling
procedures could affect subsequent behavior of blastomere-derived daughter cells [6-7],
preventing findings from being applicable to undisturbed embryos. For instance, an early
observation that the earliest dividing 4-cell blastomere contributes disproportionately to the
ICM [4] could not be confirmed in later experiments using live imaging [8].
Less-invasive markers, such as membrane-labeling dyes, and intrinsic features of the
embryo [9-11], sometimes combined with time-lapse imaging [10, 12], have also been used
to assess blastomere fate. These studies primarily focused on the contribution of 2-cell stage
blastomere daughters to the embryonic region (Em) of the blastocyst, containing the ICM
and the overlying polar TE or the abembryonic region (Ab), containing the mural TE
surrounding the blastocoel cavity. In one study, the second polar body was observed to
localize consistently to the Em-Ab boundary of the blastocyst, suggesting that different
regions of the zygote might have distinct fates [9]. In another, the location of the sperm
entry point was proposed to influence Em-Ab orientation of the blastocyst [6]. Consistent
with these observations, transplantation of cytoplasm from the animal pole of the zygote to
an ectopic location was observed to alter the orientation of the first cleavage division [11].
However, embryos lacking either animal or a vegetal cytoplasm are able to develop to term,
suggesting that neither is necessary for development [13]. Furthermore, experiments
utilizing time-lapse imaging indicated that bias might only occur in embryos with an intact
zona pellucida (ZP), and disappears when the ZP is removed. Thus, bias could also result
from extrinsic constraints rather than from intrinsic differences between the blastomeres [12,
14]. All these experiments necessitated pooling results from multiple embryos for statistical
analysis, making it possible that a subpopulation of embryos displaying significant bias was
not detected [6-7, 10-12, 14-16].
More recent studies have used time-lapse imaging of fluorescently labeled nuclei to track
blastomere daughters to the early blastocyst stage and assess their Em-Ab contribution [8,
17-18]. Some observers suggested that certain orientations of cleavage division from the 2-
cell stage to the 4-cell stage may produce blastomere daughters with bias to contribute to the
Em region [8]. An independent experiment analyzing this relationship found that the
observed bias could be eliminated by removal of the ZP, and may be a property of
embryonic geometry as opposed to intrinsic differences between cells [17].
Tabansky et al. Page 2
Curr Biol. Author manuscript; available in PMC 2014 January 07.
$watermark-text
$watermark-text
$watermark-text
Subsequent studies focused on detecting intrinsic differences between blastomeres. Higher
levels of histone 3 arginine 26 methylation (H3R26m) in 4-cell blastomeres have been
proposed to be associated with an increased contribution of daughter cells to the ICM and
polar TE [19-20]. Fluorescence decay after photoactivation also reveled differences between
4-cell blastomeres with regard to accessibility of nuclear DNA to binding by the ICM
transcription factor Oct4 [21]. Blastomeres where Oct4 bound to DNA more strongly
displayed a tendency to divide asymmetrically, resulting in their daughter cells contributing
to the ICM [21-22].
Despite a large number of studies examining the issue of blastomere bias, several important
questions remain to be addressed. It is still unclear whether the pattern of contribution of
blastomere daughters to distinct regions of the blastocyst (ICM/TE or Em/Ab) can be
accounted for by random allocation. Furthermore, the exact nature of the relationship
between Em-Ab and TE-ICM contribution, if any, still remains to be determined. Finally, it
is important to ascertain what relevance the bias observed at preimplantation stages has for
the postimplantation embryo. To provide new insight into the fate of mouse blastomeres, we
have developed and employed a non-invasive, heritable, multi-color lineage tracing strategy.
Our finings provide new answers to each of these questions and are consistent with the
proposal that blastomeres arising from certain cell division patterns may inherit epigenetic
factors predisposing them either to an ICM or a TE cell fate.
Results
Generation and characterization of Rainbow mice
Multi-color lineage tracing was achieved through modification of a combinatorial
fluorescent labeling method originally developed for tracing neuronal projections, called the
Brainbow [23]. In Brainbow mice, stochastic action of Cre recombinase on sets of target
(Lox) sites results in expression of varying combinations of fluorescent proteins, creating
unique color labels for individual cells (Figure S1A). Greater numbers of Brainbow loci
within the genome result in increased numbers of possible color combinations (Figure S1B).
To allow multi-color lineage tracing in many organs at various stages of development, we
constructed a transgene in which the broadly-expressed CAGGS promoter [24-26] was
placed upstream of the brainbow1.0 construct [23](Figure 1A). After validating the
multicolor labeling efficacy of our construct in a heterologous expression system (Figure
1B), we used pronuclear injection to generate transgenic mice. We obtained 3 founder
animals with strong, ubiquitous red fluorescent protein (RFP) expression (Rainbow1-3;
Figure 1C and Figure S2).
We observed robust expression of RFP in almost all tissues of adult rainbow2 animals
(Figure S2A). Flow cytometry demonstrated that more than 80% of splenocytes and 90% of
thymocytes, including B- and T-cells, also expressed RFP (Figure S2B). RFP was also
observed in transgenic embryos at E3, E4.5, E6.5, E9.5, E14.5 and in neonates (Figure 1C,
2A, 3B).
To test whether recombination could be induced in vivo, we crossed Rainbow animals to
CAGGS:CreERTM2 (CreER) mice that allow for temporal control of Cre activity through
exposure to 4-hydroxytamoxifen (4-OHT), which is the active metabolite of the drug
tamoxifen [27]. When pregnant females were treated with tamoxifen at E13.5, and the
embryos isolated and sectioned 2 days later, we observed many distinct colors in various
tissues (Figure 2A).
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To test recombination efficiency in preimplantation embryos, we isolated zygotes from
rainbow2 females crossed to CreER males, cultured these embryos until the morula stage,
exposed them to 4-OHT, and then quantified the number of colors in the resulting
blastocysts (Figure 2B). Recombination was undetectable in the absence of CreER and
extremely rare without 4-OHT exposure (4/1157 recombined cells in 12 blastocysts) (Figure
3B). In striking contrast, embryos treated with 4-OHT were observed to contain cells with
many distinct color combinations (Figure 2B, 3C-D, Figure S3).
Redundant recombination events causing multiple cells to be labeled with the same color are
a concern in these experiments as the progeny of such cells would be indistinguishable from
each other. Increasing the number of possible color combinations would decrease the
probability of such events. When we quantified the ratios of CFP, YFP, and RFP in
rainbow2 embryos we observed at least 21 distinct color combinations within a single
imaging session (as many as 27 total colors for all imaging sessions, Figure S1). For the
rainbow3 and rainbow1 lines, 10 and 6 distinct color combinations could be observed,
respectively. Although the utility of each Rainbow mouse line is likely to differ depending
on experimental context, we selected rainbow2 for our experiments due to the large number
of colors produced.
Results of recombination induction at the cleavage stages
We next tested whether the Rainbow system could be used to label blastomere daughters.
We isolated Rainbow2; CreER zygotes and induced recombination with 4-OHT treatment at
the 4-cell stage, 48 hours after administration of human chorionic gonadotrophin, (HCG).
Following in vitro culture to the expanded blastocyst stage, confocal image analysis of the
resulting blastocysts revealed groups of cells of distinct colors, which appeared to be clones
(Figure 3C, Figure S3). When relative ratios of red, blue, and yellow fluorescence in each of
these cells were plotted on a 3-dimensional scatterplot, they segregated into distinct groups,
confirming the accuracy of color assignments (Figure S1 D).
Most clones observed in these embryos comprised 1/4 or 1/8 of the blastocyst (24.8±6.3% of
embryo for 24/33 clones; 11.0±2.0% for 7/33 clones; Figure 3C-D, 4C, Figure S3). Cell
divisions in the preimplantation mouse embryo up to the 6th cleavage (when our analysis
was performed) have been reported to be relatively synchronized [28-29]. Therefore, these
clones likely arose as a result of recombination in 4- and 8-cell blastomeres. We tested this
assumption by inducing recombination at the 4-cell stage and arresting the embryos at the 8-
cell stage with the DNA synthesis inhibitor aphidicolin, to allow accumulation of fluorescent
proteins (Figure 4A, B). When analyzed, 91% of the resulting 8-cell embryos (10/11) were
observed to contain at least one pair of cells of the same color, indicating that many
temporally stable 4-cell stage recombination events had occurred (Figure 4A, B).
As we had already observed that clone sizes in embryos treated at the morula stage are
considerably smaller than in those treated at the 4-cell stage (Figure 2, Figure S6), it seemed
likely that the size of the clones observed in the blastocyst was dependent on the timing of 4-
OHT treatment. To test this further, we next quantified clone sizes in blastocysts that had
been treated with 4-OHT at the late 4-cell/early 8-cell stage (59 hours post HCG), (Figure
3A, D, Figure 4C, Figure S6B). This later exposure would be expected to label 8-cell and
16-cell stage blastomeres and therefore generate clone sizes intermediate in size between
those obtained from morula and 4-cell treatments. Indeed, 12/31 clones comprised 12±2.5%
of the total cells in the embryo, while 11/31 clones comprised 5.8±1.1%. Only 3/31 clones
comprised 1/4 (on average 21.1±2.9%) of these blastocyst; Figure 3D and 4C; Figure S6).
On average, these later clones comprised 9±6% of the blastocyst, as opposed to 21±11% for
the 4-cell stage treatment. Thus, the contribution of these uniquely labeled clones to the
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blastocyst was consistent with most recombination events occurring during a cleavage
division synchronous with the 4-OHT pulse (Figure 4C).
The above observations are all consistent with Rainbow colors functioning as independent
markers indicative of blastomere lineage. Based on this, we formulated a statistical model
designed to test for random allocation of labeled cells to the ICM and TE. If cells have no
bias to contribute to either lineage, then each clone would be expected to comprise a portion
of the ICM and TE that is proportional to that clone’s prevalence within the blastocyst.
Under this model, some clones would be expected to contribute disproportionately to the TE
simply by chance, as the number of cells in the ICM is much smaller than the number of
cells in the TE. In contrast, significant and reproducible deviation from proportional
contribution to the TE and ICM would indicate that daughters of different blastomeres are
non-randomly allocated to these two lineages.
The null hypothesis in our analysis was that the probability that any given cell will
contribute to the ICM is independent of color label. To test this null hypothesis, we used
Fisher’s test, which is suitable for analysis of small samples. Non-recombined (red) cells
were excluded from our analysis, as we could not readily determine their provenance.
Importantly, we were able to assign cells to the TE and ICM with 99% accuracy (456/461
cells of 6 embryos, e.g. Figure S6).
We first used this statistical model to test the hypothesis that blastomere daughters are
randomly allocated to the TE and ICM in embryos treated with 4-OHT at the 8-cell stage.
We observed a statistically significant bias in 1 of 5 embryos examined (n=31 clones from 5
embryos; p<0.05 by Fisher’s test using independence of color to ICM contribution as the
null hypothesis; Figure 3D, Figure S6 and Table S1).
As our analysis included several embryos, each of which represented a separate statistical
test, we would expect to observe some bias simply by chance, as a result of testing multiple
samples. Therefore, we performed a Monte-Carlo simulation to determine the likelihood that
our results were obtained entirely by chance and to compute an aggregate p-value for the
data set. The aggregate p-value as computed by Monte-Carlo simulation for embryos treated
with 4-OHT at the 8-cell stage was 1.22×10−3. Thus, it is unlikely that bias we observed in
this data set could be explained by chance, allowing us to reject the null hypothesis of
independence between color labels and ICM contribution.
It is important to note that embryos containing dead blastomeres were excluded from our
analysis (Figure S4C), and that the relative proportion of ICM to TE cells remained
unchanged, even after prolonged 4-OHT treatment (Figure S4A-B). Thus, our observation of
bias could not be explained by either selective death of blastomeres or biological effects of
the 4-OHT pulse.
We next performed a similar analysis on embryos that had been treated with 4-OHT at the 4-
cell stage. In this data set, we observed a significant deviation from random allocation in
30% of the embryos assayed (n=62 clones from 21 embryos; Figure 3C, Figure S3 and
Table S2;). The aggregate p-value for this data set as determined by Monte-Carlo simulation
was 3 × 10−9, indicating that our results were highly unlikely to be accounted for by chance.
The increased proportion of biased embryos observed after 4-cell 4-OHT treatment, as
opposed to the 8-cell 4-OHT treatment, is most likely a result of our enhanced ability to
detect bias in the 4-cell treated data set. The earlier 4-OHT treatment produced larger clones,
resulting in greater statistical power.
Importantly, embryos with detectable bias were comparable to unbiased embryos with
regard to total number of cells (biased: 73±15, unbiased: 72±28), and the percentage of total
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cells that contributed to the ICM (biased:12%±4%, unbiased: 16%±3%). As we observed a
large number of colors that occurred with approximately equal frequency (Tables S3 and 4,
Figure S1) it is likely that most recombination events that we analyzed were unique. Thus
our results suggest that many 4-cell embryos contain developmentally non-equivalent
blastomeres, but previous studies indicate that they are unlikely to be lineage restricted[30],
unlike progenitors in other eukaryotes, such as Drosophila imaginal disks[31].
Relationship between spatial localization of clones and their TE-ICM contribution
It has recently been proposed that differences between 4-cell blastomeres can result in
distinct propensities to contribute to either Em, or Ab hemispheres of the blastocyst [7, 12,
15, 17, 28, 32-36]. While the ICM is by definition always in the Em hemisphere, Em-Ab
localization is a description of spatial allocation, as opposed to lineage contribution (Figure
5B). Thus, analyzing the relationship between ICM-TE and Em-Ab localization of
blastomere descendants could indicate whether the orientation of the blastocoel cavity is
dependent on the localization of clones with bias to contribute to the ICM (Figure 5C,
Figure S5C-F). If this were the case, we would expect to see a strong correlation between
clone contribution to the ICM and the Em region of the blastocyst. In contrast, if ICM-TE
bias is not a result of Em-Ab bias, we would expect that Em contribution and ICM
contribution of labeled cells to be weakly, or uncorrelated (Figure 5C). When we analyzed
the relationship between Em-Ab and TE-ICM contribution in blastocyst treated with 4-OHT
at the 4-cell stage, the resulting correlations were either small or undetectable (Figure 5A
and D-G, Figure S5C-F). Our results are consistent with a model where the orientation of the
clone(s) biased to contribute to the ICM does not impact the orientation of the blastocoel
cavity, at least at the expanded blastocyst stage (Figure 5C). It is therefore possible that Em
contribution is independent from ICM contribution starting from the time that the embryo
initiates cavitation. Alternately, morphological changes occurring during blastocyst
development could weaken the relationship between Em and ICM contribution at later
stages.
In the three-dimensional reconstruction of Rainbow embryos treated with 4-OHT at the 4-
cell stage, substantial mixing among cells of different colors was observed in the ICM. To
determine whether adhesive or migratory properties of the daughters of different
blastomeres account for variation in their ICM contribution, we attempted to detect a
correlation between the amount of cell mixing and ICM contribution. The amount of cell
mixing was determined based on the number of discrete discontinuous regions present in the
each clone. No correlation between that measure and percent of clone contributing to the
ICM was observed (R= −0.07), suggesting that differential clone adhesion and migration are
not the major mechanism by which non-random lineage allocation occurs (Figure S5B).
Maintenance of blastomere bias post-implantation
To analyze multiple clones post-implantation, we transferred blastocysts that had been
pulsed with 4-OHT at the 4-cell stage into pseudopregnant recipient females. We re-isolated
and imaged these embryos at E7.5. Three of four embryos contained 4 or fewer large clones
of distinct colors, indicating that unique labeling of 4-cell blastomeres had likely occurred.
A considerably smaller fifth clone in one embryo appeared to have arisen from a later
recombination event (Figure 6B).
To test for bias in blastomere contribution to postimplantation embryos, we quantified the
number of cells of each color in the postimplantation embryonic domain (primarily derived
from the ICM) and the postembryonic abembryonic domain (primarily derived from the TE)
of each embryo (Figure 6A). We observed clones that were highly skewed in their
contribution to either the embryonic or abembryonic domains in N = 3 of 4 embryos
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(embryo I.1 blue clone, embryo I.2 green and blue clones, and embryo I.3 purple and green
clones, Figure 6B). Other clones in these embryos did not appear biased (embryo I.1 purple
clone, embryo I.2 purple clone, Figure 6B).
When 4-OHT treatment was performed at the late 8-cell stage, and these embryos were
isolated and analyzed at E7.5, we also observed increased skewing in lineage contribution,
including a clone that was specific to the epiblast (N=3 embryos, Figure S6C). Importantly,
no recombination was detectable in control embryos that had not been exposed to 4-OHT
(Figure 6B). Thus, biased contribution of clones to different lineages is detectable
postimplantation.
Discussion
We have developed a multicolor lineage tracing method that can be used to assess the
contribution of mammalian progenitor cells to many different tissues (Figure 2, S2). The
Rainbow method, like all retrospective lineage tracing, suffers from limitations resulting
from lack of prospective information, including a limited ability to detect ectopic and
redundant recombination events. However, unlike single-color lineage tracing, our system
enables analysis of many clones within the same lineage, as multiple recombination events
to the same color would be expected to be rare. This property of the Rainbow mouse
considerably increases the information content of the data set. Systems using 4-color
labeling have proven to be useful in tissues with limited cell mixing [37-38]. However,
stochastic labeling using 4 colors in our experiments would have resulted in a considerable
number of cases where two or more blastomeres were labeled with the same color. For
instance, in a system with completely stochastic recombination and 4 possible colors, the
probability of obtaining two cells of the same color after 3 independent recombination
events would be 87%. With 10, 20, or 30 possible colors this probability would decrease to
28%,15%, and 10% respectively. Thus, the nature of our experimental system necessitated
the use of combinatorial multi-color labeling. The ability to control the rate of
recombination by varying the concentration of 4-OHT, and the relatively synchronized
nature of cell divisions during preimplantation development [28-29] allowed us to identify
and eliminate embryos with redundant recombination events based on clone size.
Using the Rainbow, we examined the contribution of uniquely labeled clones derived from
cleavage stage blastomeres to TE and ICM in individual embryos. We used statistical
analysis to show that a subset of blastomere daughters display significant bias in
contribution to either the TE or ICM. In a previous study [34], it was observed that 42% of
mouse embryos within a population exhibited a division pattern that was associated with
subsequent lineage bias of 4-cell blastomeres. Further analysis by the same group showed
that certain blastomeres derived from these cell divisions exhibit distinct levels of
H3R26me, which in turn was associated with a predisposition for contribution to either TE
and or ICM [20]. While the correlation between cell division and TE-ICM contribution
observed in these studies was indirect, it is interesting that in our experiments, a comparable
30% of embryos treated with 4-OHT at the 4-cell stage displayed significant bias. It is
important to note that cleavage pattern frequencies may be variable depending on mouse
strain used and other environmental factors. Therefore, it is not unreasonable to expect that
the proportion of biased embryos observed would not be precisely identical between studies
[8, 17-18, 10-12, 14-16]. The proportion of biased embryos observed in our study is
therefore consistent with the proposal that certain orientations of cleavage divisions may
confer lineage bias onto 4-cell blastomeres [19-20, 33-34]. It has yet to be determined how
these variations in cleavage patterns result in epigenetic differences, such as varying levels
of H3R26me [20, 35] and differing Oct4 DNA-binding dynamics at the 4-cell stage [21].
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One striking finding from our study is the lack of detectable correlation between Em and
ICM contribution in clones derived from 4-OHT treatment. The only significant relationship
to emerge from our analysis was a weak negative correlation between the contribution of a
given clone to the Ab region and its contribution to the ICM. This would be expected, as the
Em region by definition contains the ICM (Figure 5B). However, if bias to contribute to the
ICM were the result of preferential contribution to the Em region, we would also expect a
strong positive correlation between ICM contribution and Em contribution. Such a
correlation was not observed, suggesting that independent mechanisms may drive
blastomere contribution to the Em and ICM at the expanded blastocyst stage. From a
mathematical perspective, this lack of correlation is possible because the ICM comprises
only a small portion of the Emb region of the embryo.
Our observation that only a small subset of clones contributes exclusively either to the Em
or Ab regions of the blastocyst is similar to the results obtained from an earlier live imaging
study [17], where it was observed that Em-Ab distribution of the daughters of 2-cell
blastomeres was strongly influenced by the orientation of the ZP [17]. This interpretation
has been contested[8]. The lack of correlation between Em and ICM contribution in our
study suggests that the orientation of the ZP, even if it is a determinant the Em-Ab axis,
cannot fully account for TE-ICM bias observed in the expanded blastocyst [17].
It may be possible that analyses of blastomere contribution to Em-Ab regions based on
parameters different from nuclear position, such as the volume of cytoplasm, may lead to
distinct findings. Alternately, if the orientation of the ICM within the blastocyst were to
change as the blastocoel cavity expanded, an earlier correlation between ICM and Em
contributions might become undetectable at later blastocyst stages, when our analysis was
performed. The mechanisms that generate various patterns of TE-ICM and Em-Ab
contribution at different stages of development would need to be examined more carefully,
in order to fully understand the mixing that blastocyst lineages undergo during blastocoel
expansion.
The genetic labeling employed by the Rainbow system allowed us to confirm a prior
observation that 4-cell blastomeres display skewed contribution to embryonic and
abembryonic lineages post-implantation [5]. In addition, we were able to demonstrate that
individual embryos can contain blastomeres exhibiting biased and unbiased contribution
patterns to the TE, ICM and their derivatives. It would be important to elucidate the
consequences that this bias, and the epigenetic differences underlying it, could have for later
development. For instance, the epigenetic differences between daughters of different
blastomeres could also influence their survival in the postimplantation embryo, and skew
contribution to various fetal lineages. As studies of blastomere non-equivalence advance
into post-implantation development, there is an opportunity to better understand effects of
blastomere bias on the resulting fetus. A better understanding of the impact of blastomere
bias could in turn help improve outcomes for patients undergoing fertility treatments or the
efficiency of embryonic development following PGD.
Experimental Procedures
The Rainbow construct was generated by ligating the brainbow1.0 construct into the
pCAGEN plasmid (Adgene). Mice were generated by pronuclear injection with linearized
Rainbow plasmid into BDF2 embryos at the Harvard Genome Modification facility. To
isolate preimplantation embryos, mice were superovulated with HCG and PMS, and mated
to males. Embryos were dissected from oviducts in HCZB media, and cultured in KSOM
media under mineral oil at 5% CO2, 37°C. To induce recombination at preimplantation
stages, embryos were pulsed for 6 hrs with 0.2 μM 4-OHT (Sigma). For aphidicolin arrest,
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embryos were cultured in KSOM supplemented with 0.05 μg/mL aphidicolin. For imaging,
embryos were mounted in HCZB supplemented with 20 μM DRAQ5 far-red nuclear dye.
Embryos were imaged live wholemount on Olympus FV1000 and Zeiss LSM710
microscopes with 440, 515, 568, and 633 lasers. For cell membrane staining, zona-denuded
blastocysts were incubated overnight in Vybrant DiO cell labeling solution (Invitrogen),
diluted 1:100 in KSOM at 37°C, 5% CO2. For postimplantation analysis, E3.5 blastocysts
were transferred into uteri of pseudopregnant females 2.5 dpc. Embryos were dissected from
the uterus at E7.5, fixed in 4% paraformaldehyde, and imaged. For recombination at E13.5,
2.5 mg Tamoxifen was administered orally to Rainbow3 females previously mated to
CAGG-CreER males. Embryos were recovered 2 days later, cryosectioned and imaged.
Most image analysis was performed using the Imaris 6.0 image processing software
(Bitplane). Nuclei were detected by far-red staining, and independently assigned a color and
a position within the blastocyst. Image J was used for quantification of relative fluorescence
intensities. For statistical analysis, each embryo was studied as a contingency table with two
outcomes but potentially varied counts of differentiable colors. Since not all clones were
large enough to support a Pearson’s Chi-squared tests, a Fisher’s p-value was calculated
using R-function fisher.test() to test against the hypothesis of independence between color
and outcome. Pearson’s r values for embryonic-ICM correlation were calculated using
Microsoft Excel.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Mouse lines for Rainbow lineage tracing in many tissues and developmental
stages.
• A fraction of blastocysts exhibited biased clone contribution to the TE/ICM
• TE/ICM bias was uncorrelated with embryonic/abembryonic distribution of
clones
• Postimplantation embryos had skewed contribution of clones to distinct lineages
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Figure 1. A mouse for Rainbow lineage tracing
(A) The Rainbow construct. (B) Rainbow recombination after co-transfection with Cre into
HEK cells. (C) dTomato expression at E6.5, E9.5, and in P1 Rainbow2 pups. See also
Figure S1.
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Figure 2. Expression and recombination of the Rainbow transgene
(A) Sagital section through an E14.5 Rainbow3; CreER embryo that had been treated with
4-OHT at E12.5. Scale bar = 1 mm. Top inset: dorsal root ganglia. Middle inset: lung
Bottom insert: heart muscle. (B) Wholemount confocal image of a Rainbow2; CreER
blastocyst that had been treated with 4-OHT at the morula stage. Scale bar 20 μm. See also
Figure S2.
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Figure 3. Skewed contribution of cleavage stage blastomeres to TE and ICM lineages
(A) Experimental outline: Embryos were treated with 4-OHT at different stages of
development, and contribution of each recombined clone to the ICM and TE was quantified.
Images are confocal projections of whole-mount embryos (B) An untreated Rainbow2;
CreER blastocyst, where only dTomato expression can be detected. The structure in the
lower right corner is cells hatching from the ZP. (C-D) Representative Rainbow2; CreER
embryos treated with 4-OHT at the 4-cell (C) and 8-cell (D) stages. Embryos are labeled as
biased or unbiased. Scale bars 20 μm. P = Fisher probability value for each embryo. Pie
charts represent proportional contribution of cells in each clone to the overall embryo, ICM,
or TE. The number of cells in each population is listed on the corresponding slice of the pie
chart. See also Figure S3 and Tables S1-S4.
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Figure 4. Correlation between the timing of recombination and administration of 4-OHT
(a) Representative confocal optical slices through a pharmacologically arrested 8-cell
Rainbow2 embryo that had been treated with 4-OHT at the 4-cell stage. Slice thickness 3
μm, scale bars 20 μm (b) Distribution of clone sizes in embryos experimentally arrested at
the 8-cell stage. N=44 clones. (c) Relationship between clone size at the blastocyst stage and
timing of 4-OHT treatment. See also Figures S4 and S6 and Tables S3 and S4.
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Figure 5. Comparison between embryonic-abembryonic contribution and TE-ICM bias
(a) Analysis of contribution of clones to embryonic and abembryonic regions of a
representative Rainbow embryo, showing colors, nuclei, designation of differently colored
spots, designation of the ICM and the embryonic-abembryonic axis, and contribution of
different clones to the embryonic and abembryonic halves of the embryo. (b) an illustration
of the difference between TE/ICM and Em-AB designations (c) Model: Biased contribution
of blastomeres to the ICM could be uncoupled from hemisphere bias if the blastocoel cavity
forms independently of the location of a clone that preferentially contributes to the ICM.
The number of cells in each population is listed on the corresponding slice of the pie chart.
(d-g) A comparison of ICM versus embryonic contribution in embryos that had been treated
with 4-OHT at the 4-cell stage. “Emb” indicates proportion of contribution to the embryonic
hemisphere of the blastocyst. See also Figure S5.
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Figure 6. Preferential contribution of clones resulting from 4-OHT treatment at the 4-cell stage
to different regions of postimplantation embryos
(a) Experimental outline: Embryos were induced to undergo recombination at the 4-cell
stage, transferred into pseudopregnant recipients, and re-isolated at E7.5 for analysis. (b)
Slices and 3D reconstructions of resulting embryos show skewed contribution of clones to
either embryonic or abembryonic lineages. Asterisks indicate location of ectoplacental cone.
Scale bars=100 μm. The number of cells in each population is listed on the corresponding
slice of the pie chart. See also Figure S6.
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